These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34410323)

  • 1. Use of an Analytics and Electronic Health Record-Based Approach for Targeted COVID-19 Vaccine Outreach to Marginalized Populations.
    Stein J; Fasold M; Daguerre KJ; Richardson J; Cheek S; Charlot M; Basch E
    JAMA Oncol; 2021 Oct; 7(10):1570-1572. PubMed ID: 34410323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Statewide Electronic Health Record and Influenza Vaccination Data to Plan and Prioritize COVID-19 Vaccine Outreach and Communications in Wisconsin Communities.
    Bonham-Werling J; DeLonay AJ; Stephenson K; Hendricks KA; Bednarz L; Weiss JM; Gigot M; Smith MA
    Am J Public Health; 2021 Dec; 111(12):2111-2114. PubMed ID: 34878860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Vaccination Telephone Outreach: A Primary Care Clinic Intervention Targeting Health Equity.
    Wu JF; Muntz MD; Maguire A; Beckius A; Kastner M; Hilgeman B
    WMJ; 2023 Dec; 122(5):438-443. PubMed ID: 38180942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rapid Survey of State and Territorial Public Health Partnerships With Faith-Based Organizations to Promote COVID-19 Vaccination.
    Santibañez S; Ottewell A; Harper-Hardy P; Ryan E; Christensen H; Smith N
    Am J Public Health; 2022 Mar; 112(3):397-400. PubMed ID: 35196042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equitable Access and Distribution of COVID-19 Vaccines for US Vulnerable Populations: Federal Health Center Program Perspective.
    Lin SC
    Am J Public Health; 2021 Jun; 111(6):1070-1072. PubMed ID: 33950721
    [No Abstract]   [Full Text] [Related]  

  • 6. Advocating for Greater Inclusion of Marginalized and Forgotten Populations in COVID19 Vaccine Rollouts.
    Farina M; Lavazza A
    Int J Public Health; 2021; 66():1604036. PubMed ID: 34707472
    [No Abstract]   [Full Text] [Related]  

  • 7. Communicating COVID-19 vaccines: lessons from the dengue vaccine controversy in the Philippines.
    Lasco G; Yu VG
    BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33653732
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 and global equity for health: The good, the bad, and the wicked.
    Geng EH; Reid MJA; Goosby E; Abdool-Karim Q
    PLoS Med; 2021 Oct; 18(10):e1003797. PubMed ID: 34597296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technologies to advance COVID-19 vaccine equity.
    Nat Biotechnol; 2021 Dec; 39(12):1477. PubMed ID: 34873328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Vaccine Equity: How Community Engagement and Informatics Facilitate Health System Outreach to Underrepresented Groups.
    Xie SJ; Mah NR; Chew L; Ruud J; Hernandez J; Lowery J; Hartzler AL
    Appl Clin Inform; 2024 Jan; 15(1):129-144. PubMed ID: 38354837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the COVID-19 Vaccination Campaign
    Nawaz S; Moon KJ; Anagbonu F; Trinh A; Escobedo L; Montiel GI
    Public Health Rep; 2024; 139(1_suppl):44S-52S. PubMed ID: 37957827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Practice-based Community Outreach Intervention to Prevent Inequities in COVID-19 Vaccinations.
    Gonzalez CJ; Meltzer K; Jabri A; Zhu JJ; Lau JD; Pelzman F; Tung J
    Am J Med Qual; 2022 Jul-Aug 01; 37(4):348-355. PubMed ID: 35353474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centring equity over exceptionalism in the global covid-19 response.
    Chebly KO
    BMJ; 2022 Jan; 376():o20. PubMed ID: 34992066
    [No Abstract]   [Full Text] [Related]  

  • 14. Development, Implementation, and Evaluation of Three Outreach Events to Improve COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Communities in Houston, Texas, 2022.
    Munoz-Lavanderos C; Oluyomi A; Rosales O; Hernandez N; Mensah-Bonsu N; Badr H
    Public Health Rep; 2024; 139(1_suppl):71S-80S. PubMed ID: 38140821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving COVID-19 vaccine acceptance: Including insights from human decision-making under conditions of uncertainty and human-centered design.
    Poland CM; Matthews AKS; Poland GA
    Vaccine; 2021 Mar; 39(11):1547-1550. PubMed ID: 33612343
    [No Abstract]   [Full Text] [Related]  

  • 16. Deployment of Health Equity Strike Teams to Address COVID-19 Vaccine Disparities in Arkansas, 2021.
    Porter A; Wells S; Smith C; Zohoori N; Pro G; Smith MR
    Am J Public Health; 2022 Jan; 112(1):29-33. PubMed ID: 34936402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Electronic Outreach Using Patient Portal Messages on Well Child Care Visit Completion: A Randomized Clinical Trial.
    Berset AE; Burkhardt MC; Xu Y; Mescher A; Brinkman WB
    JAMA Netw Open; 2022 Nov; 5(11):e2242853. PubMed ID: 36399342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    Rid A; Lipsitch M; Miller FG
    JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
    [No Abstract]   [Full Text] [Related]  

  • 19. Reporting of health equity considerations in vaccine trials for COVID-19: a methodological review.
    Kou R; Sadafi SL; Principato R; Anderson LN; Brignardello-Petersen R; Mbuagbaw L
    J Clin Epidemiol; 2024 May; 169():111315. PubMed ID: 38447854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine Literacy-helping Everyone Decide to Accept Vaccination.
    Ratzan SC; Parker RM
    J Health Commun; 2020 Oct; 25(10):750-752. PubMed ID: 33719880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.